Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
conbercept (Lumitin) (1 trial)
Macular Degeneration (Phase 2)
Wet Macular Degeneration (Phase 2)
Trials (1 total)
Trial APIs (1 total)